openPR Logo
Press release

Endocrine Testing Market Technological Innovations, Key Developments Players Abbott, Thermo Fisher Scientific, Beckman Coulter, Siemens Healthineers, bioMérieux

04-13-2019 09:36 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Coherent Market Insights

Endocrine Testing

Endocrine Testing

Endocrine testing involves measuring of endocrine hormone concentration in order to diagnose the various disorders such as diabetes, hypothyroidism, infertility, and other hormonal disorder. Endocrine glands secret hormones directly into bloodstream thereby helping in regulation of various body functions such as growth and development, metabolism, reproduction, stimuli response, and homeostasis. Various endocrine glands present in body include pituitary glands, thyroid glands, hypothalamus, pancreas, and adrenal glands. Any imbalance in the hormones secreted by this glands leads to certain disorder therefore they are important marker to diagnose certain condition. Endocrine testing involves testing of the hormones such as insulin, thyroid stimulating hormone, follicle stimulating hormones, human chorionic gonadotropin, progesterone, testosterone, cortisol, prolactin, and other hormones. Various assay kits are used in order to determine the concentration of hormone. It confirms presence of lower than normal or upper than normal range of hormone in blood, thereby indicating the disorder.

The global endocrine testing market was valued at US$ 2.95 billion in 2017, and is expected to witness a CAGR of 4.9% over the forecast period (2018 – 2026).

Request For Sample Copy:
https://www.coherentmarketinsights.com/insight/request-sample/1755

Global Endocrine Testing Market, By Product:
Thyroid
Insulin
Follicle Stimulating Hormone
Luteinizing Hormone
Estradiol
Testosterone
Progesterone
Human chorionic gonadotropin
Prolactin
Cortisol
DHEA-S
Others

Companies are launching innovative products to cater the end user need and increase the market footprint in the endocrine testing market. In 2017, Beckman Coulter Diagnostics received FDA clearance of its automated Access AMH immunoassay for in vitro diagnostic (IVD) use. AMH test helps healthcare providers in the assessment of a woman's ovarian reserve, thereby aid in the clinical management of women facing infertility or women planning to become pregnant later in life. The Access AMH assay is a paramagnetic particle chemiluminescent immunoassay for the quantitative determination of AMH levels. The test can be used in conjunction with other clinical and laboratory findings such as antral follicle count, before starting fertility therapy. Companies are also undergoing strategic collaboration to increase market share. For instance, in 2017, Quest diagnostics and Walmart collaborated, under which Quest would open laboratory testing services at 15 Walmart locations initially to gradually increase same.

Key companies covered as a part of this study include Abbott Laboratories, Thermo Fisher Scientific, Beckman Coulter, Inc., Siemens Healthineers, bioMérieux SA, Agilent Technologies, BioRad Laboratories, AB Sciex, F-Hoffmann La Roche AG, Quest Diagnostics, and others.

Major factor driving growth of the endocrine testing market is increasing prevalence of endocrinal disease which requires first point diagnosis. Cushing syndrome is one of major endocrinal disorder. Cushing syndrome is result of the excess exposure to hormone cortisol. Cortisol concentration may elevate due to longer treatment of chronic asthma or rheumatoid arthritis and other causes. According to American Association of Neurological Surgeon statistics, around 10-15 per million people are affected by Cushing syndrome every year. Prevalence of postmenopausal osteoporosis is high, owing to low production of estradiol in women. According to International Osteoporosis Foundation factsheet, around 30% of all postmenopausal women have osteoporosis in the US and in Europe. Among them, 40% of women suffer from one or more fragility fractures in their lifetime. Increasing ageing population is also expected to aid in growth of the endocrine testing market, owing to high prevalence of endocrinal disease. According to population Prospect report by United Nations in 2017, an estimated 962 million people are aged 60 or above in the world, which accounted for 13% of the global population. The number of older people in the world is projected to be 1.4 billion growing at annual rate of 3% by 2030.

Download the PDF brochure:
https://www.coherentmarketinsights.com/insight/request-pdf/1755

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

1001 4th Ave

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Endocrine Testing Market Technological Innovations, Key Developments Players Abbott, Thermo Fisher Scientific, Beckman Coulter, Siemens Healthineers, bioMérieux here

News-ID: 1702076 • Views:

More Releases from Coherent Market Insights

Prebiotics for Dietary Supplements Market See Incredible Growth 2024-2031 | Clasado Biosciences, VW-Ingredients, Shandong Longli Biotechnology Co., Ltd, Prenexus Health., Ingredion, Tata Chemicals Ltd., Yakult Honsha Co., Ltd., Tate & Lyle, Roquette Frèr
Prebiotics for Dietary Supplements Market See Incredible Growth 2024-2031 | Clas …
Coherent Market Insights Published Most recent Prebiotics for Dietary Supplements Market Study by in-depth analysis of the current scenario, the Market size, demand, growth pattern, trends, and forecast. This report on the study considers important factors such as an analysis of the market, a definition of the market, market segmentation, significant trends in the industry, an examination of the competitive landscape, and research methodology. For achieving incredible growth in business,
DNA Repair Drugs Market Expected to Expand at a Steady 2024-2031 | AstraZeneca Plc., Johnson & Johnson, GlaxoSmithKline plc., Pfizer, Inc., Clovis Oncology Inc., AbbVie Inc., Bristol - Myers Squibb, Merck KGaA, Genentech, Inc., Repare Therapeutics Inc., K
DNA Repair Drugs Market Expected to Expand at a Steady 2024-2031 | AstraZeneca P …
Coherent Market Insights Published Most recent DNA Repair Drugs Market Study by in-depth analysis of the current scenario, the Market size, demand, growth pattern, trends, and forecast. This report on the study considers important factors such as an analysis of the market, a definition of the market, market segmentation, significant trends in the industry, an examination of the competitive landscape, and research methodology. For achieving incredible growth in business, this
Polyethylene Terephthalate (PET) Market 2024-2031: Raw Materials Requirements, Manufacturing Process, Business Plan | Alpek S.A.B de C.V., RTP Company, BASF SE
Polyethylene Terephthalate (PET) Market 2024-2031: Raw Materials Requirements, M …
This comprehensive Report of the Polyethylene Terephthalate (PET) Market provides real information about the statistics and state of the global and regional market. Its scope study extends from the market situation to comparative pricing between the main players, spending in specific market areas, and profits. A complete and wide-ranging evaluation of the aspects that drive and restrain market growth is also provided throughout the study. This detailed exploration of the
Chlorine Market 2024-2031: Business Plan, Manufacturing Process, Machinery Requirement | BASF SE, Occidental Chemical Corporation
Chlorine Market 2024-2031: Business Plan, Manufacturing Process, Machinery Requi …
This comprehensive Report of the Chlorine Market provides real information about the statistics and state of the global and regional market. Its scope study extends from the market situation to comparative pricing between the main players, spending in specific market areas, and profits. A complete and wide-ranging evaluation of the aspects that drive and restrain market growth is also provided throughout the study. This detailed exploration of the market size

All 5 Releases


More Releases for Endocrine

Endocrine Testing Market Growth Is Attributed to Increasing Prevalence of Endocr …
Endocrine testing is an important diagnostic technique used to identify endocrine hormone level in the human body. It is utilized to diagnose hormone-related illnesses. Endocrine system consists of various glands such as pituitary gland, thyroid, pancreas, hypothalamus, and adrenal glands. Hormones secreted by these glands are used to maintain various biological functions of the body. Thus, imbalance in the concentrations of hormones may lead to certain conditions. Endocrine testing is
Endocrine Testing Market Growth Is Attributed to Increasing Prevalence of Endocr …
Endocrine testing is an important diagnostic technique used to identify endocrine hormone level in the human body. It is utilized to diagnose hormone-related illnesses. Endocrine system consists of various glands such as pituitary gland, thyroid, pancreas, hypothalamus, and adrenal glands. Hormones secreted by these glands are used to maintain various biological functions of the body. Thus, imbalance in the concentrations of hormones may lead to certain conditions. Endocrine testing is
Endocrine testing market is driven by the increasing incidences of endocrine dis …
The endocrine system comprises of the endocrine glands such as the pituitary, thyroid, pancreas, adrenal, etc. These glands secrete hormones that regulate the body’s metabolism, growth, sexual development, and function. Endocrine tests help in assessing the normal functioning of the endocrine gland by checking the hormone levels. Get a sample report @ https://www.alliedmarketresearch.com/request-toc-and-sample/306?utm_source=openpr&utm_medium=Niranjan The tests detect the imbalance in hormonal levels. The various tests, their advantages, and uses are described
Endocrine Testing Market - Size, Share, 2026
Endocrine testing procedure consist of measuring concentration of endocrinal hormones in blood or urine. These hormones are precise marker for presence of endocrinal disease such as hypo/hyperthyroidism, infertility etc. Various endocrine glands present in body include pituitary glands, thyroid glands, hypothalamus, pancreas, and adrenal glands. Any imbalance in the hormones secreted by this glands leads to certain disorder therefore they are important marker to diagnose certain condition. Get PDF Research Brochure
Endocrine Testing Market: Research Methodology
The global endocrine testing market features a fairly oligopolistic structure with the top five players occupying a combined market share of 90.0% in 2014, finds Transparency Market Research (TMR). These companies are Siemens Healthineers, DiaSorin, Agilent Technologies, Abbott Laboratories, and F. Hoffmann-La Roche AG. Among the leading players, Roche emerged as the dominant players in 2014. The leading companies are developing advanced lab automation systems, next-generation sequencing platforms, endocrine test
Global Endocrine Testing Market: Regular Monitoring of Endocrine in Management o …
The global endocrine testing market features a fairly oligopolistic structure with the top five players occupying a combined market share of 90.0% in 2014, finds Transparency Market Research (TMR). These companies are Siemens Healthineers, DiaSorin, Agilent Technologies, Abbott Laboratories, and F. Hoffmann-La Roche AG. Among the leading players, Roche emerged as the dominant players in 2014. The leading companies are developing advanced lab automation systems, next-generation sequencing platforms, endocrine test